Answers are grounded in this paper and cite their sources.
Presented is an overview of how semiconductor technology is now being used for early detection on therapy of disease. Specifically two areas are described, which are currently utilising CMOS technology with tremendous benefit in healthcare. The first is in genomics, whereby advances in CMOS-based ISFET technology is now allowing implementation of point-of-care diagnostic systems as well as genetic sequencing systems which are scalable, miniature and fabricated at low cost, and the second is in bioinspired prosthetics, whereby low-power CMOS-based systems can be designed to replicate biology to provide implantable and portable devices for personalised therapy of conditions such as diabetes.
No takes yet. Share an insight, caveat, or question.
Georgiou et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: